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Editorial on the Research Topic
Plant Genome Editing – Policies and Governance
Genome editing and modification techniques are tools for sequence-specific changes in the plant
genome. These techniques enable breeders to introduce single point mutations or new DNA
sequences at a specific location in the plant genome thus for the first time enabling the precise
modulation of traits of interest with unprecedented control and efficiency. The advent of genome
editing has evoked enthusiasm but also controversy, creating regulatory and governance challenges
worldwide. In this scenario, the Research Topic “Plant Genome Editing—Policies and Governance”
aimed at collecting articles on the latest advancements and future targets of genome editing, as
well as contributions addressing the regulatory, social and socioeconomic aspects, the ethics, risk
assessment, management, and biosafety researches. In the following, key ideas contributed to this
Research Topic are summarized which serve to illustrate the broad and complex landscape of ideas
that must be addressed for plant genome editing to succeed.
THE CONTEXT—GENOME EDITING IN AGRICULTURE
The review article by Sedeek et al. provides a broad perspective on how plant genome editing
can improve crop traits in a targeted manner. The paper highlights the TALEN and CRISPR/Cas
approaches providing a general overview on the historical development of the techniques and the
problems which have been addressed by targeted genome editing. It focuses on practical examples
improving abiotic and biotic stress resistance as well as the improvement of yield and nutritional
values. Furthermore, a short excurse provides a short overview on the regulation of genome edited
crops in the US and Europe.
The paper by Nadakuduti et al. also deals with targeted improvement of crops with emphasis on
improving clonally propagated crops—esp. polyploids—with a special focus on potato. It provides
a general overview about the delivery of genome editing tools into plants and stresses special
challenges associated with genome editing in clonally propagated crops with potato as a practical
example. The authors further provide a list of clonally propagated crops which have been improved
by genome editing and traits which have been addressed in the individual crops.
Metje-Sprink et al. present a special application of genome editing in crops in which no DNA is
used for targeted genome modification. The authors present the different methods of performing
DNA-free genome editing and current applications of DNA-free genome editing in the plant sector
by providing a list of DNA-free genome applications based on a systematic literature search.
Furthermore, an overview about the current and potential future delivery methods of DNA-free
genome editing reagents is provided and a comprehensive overview on the current regulation of
genome editing in a global perspective is given.
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GENOME EDITING POLICY IN EUROPE
On 25 July 2018, the European Court of Justice ruled on
the interpretation of the definition of the term “genetically
modified organism” in the GMO Directive 2001/18/EC.
It follows from the ruling that all organisms produced by
genome editing are subject to the legal framework applicable
to release, placing on the market, labeling, and traceability
of GMOs. In their recently published statement “Toward a
scientifically justified, differentiated regulation of genome edited
plants in the EU” (https://www.leopoldina.org/uploads/tx_
leopublication/2019_Stellungnahme_Genomeditierte_Pflanzen_
web_02.pdf), German science academies and the German
Research Foundation conclude that, “due to the mounting
divergence between scientific progress and legal standardization,
the primarily process-based European regulatory approach
is no longer justifiable” and that “potential risks can only
emanate from the modified traits of the organism as a product
of the breeding process, and not from the process itself.”
Consequently, the statement proposes—as a first step—to
amend the European genetic engineering regulation in the
short term. “In a second, long term step, the legal framework
should be fundamentally overhauled to place the focus on
novel traits and features of an organism that are relevant to
the environment, health, and nature conservation, not on the
underlying breeding process.”
Legal and procedural uncertainties regarding genome edited
organisms and possible ways forward for European GMO policy
are described by Wasmer. He proposes that in a first step “the
authorization procedure for GMO release can be tailored to
different types of organisms by making use of existing flexibilities
in GMO law.” Since European competitiveness and research
in green biotechnology will suffer if the problems of current
GMO law are ignored, in a second step “any way forward has
to aim at amending, supplementing or replacing the European
GMO Directive.”
How the genome editing policy in Europe is obstructing
the development of new traits and is negatively influencing
governance decisions and trade worldwide is described by
Jouanin et al. for wheat with hypoimmunogenic gluten and by
Fritsche et al. for New Zealand. Wheat with hypoimmunogenic
gluten exemplifies the potential of genome editing for improving
crops for human consumption where conventional breeding
cannot succeed. Due to strict regulation of unintended risks
at the expense of reducing the existing immunogenicity risks
of patients these healthy products may become available in
other parts of the world but not in Europe. Jouanin et al.
strongly recommend implementing the innovation principle and
argue that “Responsible Research and Innovation, involving
stakeholders including patient societies in the development
of gene-editing products, will enable progress toward healthy
products and encourage public acceptance.” After discussing
the potentials and the current regulation of genome editing
in New Zealand, Fritsche et al. emphasize that for the global
competitiveness of a predominantly food exporting country like
New Zealand it is important that innovative technologies such as
genome editing are supported by modern legislation.
With his opinion on the “politicization of the precautionary
principle,” Aerni has put his “finger in the wound” of the
debate on genetic engineering in Europe, which is characterized
more by fear than expertise. At the same time, he discusses
which consequences it can have for Europe, also in view
to world trade, when the precautionary principle in genetic
engineering legislations is abused as an argument for avoidance
and an instrument of prevention without a science-based
risk assessment.
The controversial debate whether at all and how to regulate
genome edited plants has essentially led to the formation of
two opposing schools of thoughts. Those who consider (certain
types of) genome edited plants of low or negligible risks
and argue for no or less regulation and those who highlight
uncertainties and knowledge gaps and ask for same or similar
regulations as for GMOs. The contributions by, Eckerstorfer et al.
and Agapito-Tenfen et al. follow the latter type of thoughts.
Against the backdrop of calls for regulatory reform in the EU
Eckerstorfer et al. argue in favor of establishing a case-specific
risk assessment for genome edited plants within the existing
regulatory and biosafety framework. They suggest the EFSA
guidance documents on GMO risk assessment to be updated
allowing the risk assessment to be tailored to the level of
uncertainties to be expected—depending on the novelty of trait
/ plant-use combinations, depth of genetic intervention, etc.
This might also allow for a “risk assessment light” in case of
minimal changes and of familiarity with a given trait/plant-use.
A similar view is held by Agapito-Tenfen et al.. They conclude
that a broader societal consensus is necessary for proceeding with
genome editing and that research and innovation need to be
governed not only by biosafety but also by societal needs, ethical
principles, and sustainable development.
By comparing existing regulatory frameworks in the EU
and non-EU countries, Eckerstorfer Engelhard et al. conclude
that genome edited plants pose challenges for both process-
triggered regulations (such as in the EU) and product-triggered
systems (such as in the USA) and that eventually judicial
and/or political decisions are needed to clarify if genome
edited plants are covered by existing regulations. These still
ongoing decision-making processes, however, are heading in very
different directions, resulting in complex geographical patterns
of different regulations. As harmonization is likely to take time
and in order not to hamper international trade, they suggest an
international public register for all GMOs including also all nGM
in all jurisdictions—whether they are regulated or not.
The analysis of Bartkowski and Baum focusses on two main
types of public action to express dissatisfaction, purchasing
decisions as consumers (exit) and expressing views in deliberative
settings (voice). According to their analysis the criticism on
genome edited plants could represent a delayed response on
the part of consumer-citizens to previous grievances, specifically
because of their previously limited options to express their views.
Following their line of thoughts, calls from both science and
industry to reduce options for exit (by arguing that labeling is
not possible or not necessary) might increase the level of citizen-
consumer dissatisfaction. The authors suggest to extend the
options for deliberation when further developing the regulatory
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framework with respect to genome edited plants. At the same
time, they acknowledge the limitations and weaknesses of such
practices, such as the constraints of power dynamics and the role
of emotions. Further progress in application of the exit–voice
framework can prove useful by, inter alia, helping to establish
the preconditions and institutional forms necessary for such
strategies to be able to effectively express (and resolve) the sources
of popular dissatisfaction with the food sector.
ALTERNATIVE GOVERNANCE
APPROACHES
The disruptive energy of genome editing in plant biotechnology
initiated discussions about the appropriateness of legal
frameworks in many countries. Wolt and Wolf provide a
generic overview of the US Coordinated Framework for
Biotechnology and implications for further decision making.
Though in the USA products derived from biotechnology are
widely not considered “risky” because of the technology, societal
uncertainties about applications of genome editing led regulators
“to seek ways whereby these uncertainties may be addressed
through redefinition of those products of biotechnology that
may be subject to regulatory assessments.”
Societal uncertainty arises with regards to biosafety and
biosecurity as reported by Fears and ter Meulen from a workshop
in Hanover, Germany, in 2017. The workshop discussed potential
benefits and biosecurity concerns associated with genome editing
with regards to applications in human cells, agriculture, gene
drives, and microbiology. The authors highlight that “it is crucial
for the scientific community to share and implement good
practice in self-regulation.” Sharing perspectives, facilitating
information exchange, and identifying priorities for further
research in biosafety and biosecurity are suggested for the
scientific and biosecurity communities.
Hudson et al. discuss that modern technologies such as
genome editing are not necessarily incompatible with cultural
concepts that include living in harmony with nature and a special
sense of responsibility for the conservation of nature. Using the
example of theMaori in New Zealand, they convey an indigenous
perspective and the importance of including indigenous values in
the acceptance of new technologies such as genome editing in this
population group.
Regulatory uncertainty around new breeding techniques is
described by Lassoued et al. The success of these techniques “is
not guaranteed at the scientific level alone: political influences
and social acceptance significantly contribute to how crops will
perform in the market.” Using survey data, Lassoued et al.
report results from an international panel of experts regarding
the institutional and social barriers that might impede the
development of new technologies. “Survey results clearly indicate
that regulatory issues, social, and environmental concerns are
critical to the success of precision breeding.”
DETECTION/ENFORCEMENT
Genetic modifications that occur with some likelihood through
natural processes or conventional breeding efforts can hardly
be distinguished from equal modifications derived by genome
editing. As explained by Grohmann et al. there are several
methods and approaches available to detect small differences
between gene sequences (e.g., to a reference genome). But a
mere sequence difference tells little about the underlying process
or techniques. Extended (typical) detailed sequence information
from genome edited reference organisms would be necessary
to identify an underlying technical intervention with sufficient
certainty. The actual accessible information, technical detection
limits, natural variation in the field, and costs make it practically
impossible to track and identify unwanted traces of genome
edited plants in traded commodities.
TRIGGERS TO GUIDE APPROPRIATE AND
PROPORTIONATE GOVERNANCE
In many jurisdictions the extent to which genome edited
organisms fall under specific regulatory provisions depends on
the genetic characteristics of the edited organism, and whether
the changes introduced in its genome do (or do not) occur
naturally. Custers et al. provide a number of key considerations
to assist with this evaluation as well as a guide of concrete
examples of genetic alterations with an assessment of their
natural occurrence. “These examples support the conclusion that
for many of the common types of alterations introduced by
means of genome editing, the resulting organisms would not
be subject to specific biosafety regulatory provisions whenever
novelty of the genetic combination is a crucial determinant.”
SOCIAL AND SOCIOECONOMIC ASPECTS
In their research paper “New Plant Breeding Techniques [NPBT]
Under Food Security Pressure and Lobbying” Shao et al. show
that more strict regulations on the approval and use of NPBT
will have negative implications for food security and that the
costs of food production increase, decreasing the overall supply
of food.While decisionmakers are exposed to lobbying and lobby
groups can influence the regulation, it is important to recognize
that lobbying is not only done by one group. “The more policy
makers consider implications for food security, the less they
will be influenced by lobby groups. In the case of NPBTs, the
implication is that supporters of the technology have to lobby less
than opponents or if they lobby, they will stress the importance
of NPBTs for food security.”
ETHICS
Ethical deliberations on the regulation of genome editing
reflect the social und normative conditions for the acceptance
of molecular breeding technologies. This involves both the
justification of normative principles and the analysis of life-
world perceptions and different interests that play a role in the
implementation of plant genome editing. The first aspect is dealt
with in the article by Rippe and Willemsen. In response to
the objection that the idea of precaution cannot be rationally
justified in the end, the authors argue “for the ethical obligation to
apply precautionary measures,” provided that there is a plausible
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scientific justification for the fear of serious damage to health
and the environment. In contrast to this position, three other
contributions emphasize the limits of a mere focus on risk
issues in the question of social acceptability. Hamburger identifies
the different interests of the stakeholders and discusses existing
regulatory concepts “that are designed to facilitate a weighing
and balancing of different interests or to achieve at least a
mutual effectiveness of conflicting normative criteria.” Bogner
and Torgersen are skeptical about the existing instruments of
the Precautionary Principle (PP) and the concept of Responsible
Research and Innovation (RRI).While the PP stimulates above all
the expert discourse on risk issues, RRI focuses on a participatory
dialogue on values in agriculture, in which existing conflicts of
interest nevertheless cannot be overcome. Rather than leaving
political decisions to technical risk assessment or ethics and
public awareness, they argue for “re-establishing a broad yet
sober process of opinion formation and informed decision-
making in agricultural policy.” Bechtold is also critical of the
narrow focus on risk issues in the discourse on genome editing.
She argues for a comprehensive deliberation of values which
allow for individual decisions within our value system. As an
example, she refers to food labeling and consumer choice as
“an institution to support communication about values and to
broaden the perspective on the agricultural use of genome editing
and its products.”
Since agriculture faces major challenges to deliver food
and nutrition security the more sustainable production
of more food requires the development of crops that will
contribute significantly to attaining multiple Sustainable
Development Goals. Plant genome editing could play a key
role in developing these crops provided that accompanying
the rapid scientific progress also policy and governance
problems will be solved on national and international level. This
Research Topic will contribute to shape the technology and its
future use.
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